ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
336 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2025-04-11 (mortgagestrategy.co.uk)
L&C launches 3-year resi exclusives, Accord cuts rates by up to 25bps –
L&C Mortgages has launched an exclusive range of three-year fixed-rate residential deals, while Accord Mortgages has cut prices across its residential and landlord ranges by up to 25 basis points. L&C Mortgages offers rates from 4.02% to homeowners looking to remortgage, the products also come with a free
Read more
2023-11-15 (forbes.com)
Mortgage News: HSBC Confirms Reduced Rates As Price War Builds Momentum
We have a suite of mortgage calculators to help you work out how repayments will affect your household finances, what you could save by remortgaging, and t
Read more
2023-09-29 (forbes.com)
Mortgage News: YBS Makes Further Cuts As Rates War Continues To Rage
We have a suite of mortgage calculators to help you work out how repayments will affect your household finances, what you could save by remortgaging, and t
Read more
2022-01-24 (canadanewsmedia.ca)
Dividend hikes punctuate successful quarter for financial services firms - Investment Executive
In the quarters ended between Aug. 31 and Oct. 31, 2021, 26 of the companies reported higher year-over-year earnings; one firm, RF Capital Group Inc., posted positive net income compared to a loss a year earlier; 12 companies reported lower
Read more
2021-01-28 (prnewswire.co.uk)
Orexo Q4 2020, incl. Full Year Report
/PRNewswire/ -- Q4 2020 highlights Total net revenues of SEK 159.2 m (238.1 last year, 196.2 m excl. Abstral® EU and US) Net earnings of SEK -49.6 m (38.9)...
Read more